- Home
- UFG vs TPST Comparison
UFG vs TPST Comparison
Compare UFG & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UFG | TPST |
|---|---|---|
| Founded | 2021 | 2011 |
| Country | Singapore | United States |
| Employees | 17 | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.7M | 30.9M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | UFG | TPST |
|---|---|---|
| Price | $0.78 | $1.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 102.5K | ★ 173.9K |
| Earning Date | 04-22-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $295,000.00 |
| Revenue This Year | $3.95 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $211.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.60 | $1.50 |
| 52 Week High | $9.91 | $12.22 |
Technical Indicators
Market Signals| Indicator | UFG | TPST |
|---|---|---|
| Relative Strength Index (RSI) | 38.33 | 45.82 |
| Support Level | $0.78 | $1.57 |
| Resistance Level | $1.02 | $2.48 |
| Average True Range (ATR) | 0.07 | 0.15 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 5.67 | 35.19 |
Price Performance
Historical ComparisonAbout UFG Uni-Fuels Holdings Limited
Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.